Pfizer Animal Health Medicine Used to Treat Whales
Posted on: Sunday, 27 May 2007, 00:00 CDT
Responding to a request from the Marine Mammal Center, Pfizer Animal Health (PAH) has donated an antibiotic which was used today to treat the two humpback whales lost and injured in the Sacramento River.
"We hope mother and baby recover and find their way home," said Christina Dougherty, VMD, Senior Veterinarian, Pfizer Animal Health. Pfizer veterinarians have been working with veterinarians from the Marine Mammal Center for several days to determine the best medicine for the whales as well as the right dose for each patient.
Juan Ramon Alaix, Pfizer Animal Health President, added, "We are proud to be a part of this unprecedented administration of antibiotics to free-ranging whales but our donation of medicine is the easy part; the people doing the hard work are the veterinarians and marine biologists administering the medicine as well as those trying to herd the two whales back out to sea."
Dougherty said that whales and cows are not that dissimilar from an evolutionary perspective, so Pfizer Animal Health veterinarians proposed to the Marine Mammal Center's veterinarians that they use Excede, a Pfizer antibiotic approved in the United States and typically used to treat infections in cattle.
With sales of $2.3 billion in 2006, Pfizer Animal Health, a business of Pfizer Inc, is a global leader in discovering, developing and marketing medicines and vaccines for companion animals and livestock, including beef and dairy cattle and swine.
Source: Business Wire
Related Articles
- Diagnostic Center of Medicine Selects Allscripts Electronic Health Record and Practice Management Solution
- Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance
- Press Conference Invitation: Health Workforce Information Center (HWIC) Launch
- Pfizer Animal Health Adds Former Schering-Plough Products to European Portfolio
- Pfizer Animal Health Enters into Agreement to Acquire Animal Health Products From Schering-Plough
- ImmunoVaccine Technologies Licenses the VacciMax(R) Platform to Pfizer Animal Health for Future Animal Vaccine Applications
- Cambria Biosciences Announces Collaboration With Pfizer Animal Health in Antiparasitic Drug Discovery
- Farm Animal Veterinarians on the Decline
- Morris Animal Foundation Announces $1.1 Million Donation From Pfizer Animal Health to Establish National Canine Tumor Biospecimen Bank
User Comments (0)

RSS Feeds